Sign Up for The Checkup

Get the latest news and updates from etectRX

[contact-form-7 id="1302" title="Header Newsletter"]

High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic

COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if patients were engaged with our digital pill system when used to track and report their medication-taking in a clinical study conducted during the COVID-19 pandemic.

Read More


Share :